| 1 |
Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines |
|
|
| Jordan Ayers,Rowan J. Milner,Galaxia Cortés-Hinojosa,Alberto Riva,Sandra Bechtel,Bikash Sahay,Matthew Cascio,Amandine Lejeune,Keijiro Shiomitsu,Carlos Souza,Oscar Hernandez,Marc Salute |
|
| Journal of Veterinary Diagnostic Investigation. 2021; 33(2): 261 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
The relationship between the expression of Ki-67 and the prognosis of osteosarcoma |
|
|
| Ming Zeng,Jian Zhou,Lifang Wen,Yanshan Zhu,Yingquan Luo,Wanchun Wang |
|
| BMC Cancer. 2021; 21(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
SRPX2 Promotes Cell Proliferation and Invasion in Osteosarcoma Through Regulating Hippo Signaling Pathway |
|
|
| Zhiqiang Wu,Chunmeng Wang,Yong Chen,Zhengwang Sun,Wangjun Yan |
|
| OncoTargets and Therapy. 2020; Volume 13: 1737 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Differential Outcomes and Biologic Markers of Radiation-Associated vs. Sporadic Osteosarcoma: A Single-Institution Experience |
|
|
| Brittany L. Siontis,Jonathan B. McHugh,Emily Roberts,Lily Zhao,Dafydd G. Thomas,Dawn Owen,Laurence H. Baker,J. Sybil Biermann,Scott M. Schuetze,Rashmi Chugh |
|
| Frontiers in Oncology. 2020; 9 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Osteosarcoma of the jaws: An overview of the pathophysiological mechanisms |
|
|
| Hélios Bertin,A. Gomez-Brouchet,F. Rédini |
|
| Critical Reviews in Oncology/Hematology. 2020; 156: 103126 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
A rare case of a metastatic giant cell-rich osteosarcoma of the mandible: update and differential diagnostic considerations |
|
|
| Lucas Alves da Mota Santana,Fernanda Aragão Felix,José Alcides Almeida de Arruda,Leorik Pereira da Silva,Érika de Abreu Costa Brito,Wilton Mitsunari Takeshita,Cleverson Luciano Trento |
|
| Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
PRMT5-TRIM21 interaction regulates the senescence of osteosarcoma cells by targeting the TXNIP/p21 axis |
|
|
| Yu-Hang Li,Kui-Leung Tong,Jun-Lei Lu,Jie-Bin Lin,Zhen-Yan Li,Yuan Sang,Abdelmoumin Ghodbane,Xue-Juan Gao,Man-Seng Tam,Chang-Deng Hu,Huan-Tian Zhang,Zhen-Gang Zha |
|
| Aging. 2020; 12(3): 2507 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications |
|
|
| Pichaya Thanindratarn,Dylan C. Dean,Scott D. Nelson,Francis J. Hornicek,Zhenfeng Duan |
|
| Cancer Treatment Reviews. 2020; 82: 101934 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Overexpression of miR-335 inhibits the migration and invasion of osteosarcoma by targeting SNIP1 |
|
|
| Yuanlong Xie,Huaxin Deng,Renxiong Wei,Wenchao Sun,Yongjian Qi,Shiyi Yao,Lin Cai,Yan Wang,Zhouming Deng |
|
| International Journal of Biological Macromolecules. 2019; 133: 137 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Advanced development of ErbB family-targeted therapies in osteosarcoma treatment |
|
|
| Wei Wang,Hua-fu Zhao,Teng-fei Yao,Hao Gong |
|
| Investigational New Drugs. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Correlation between osteosarcoma and the expression of WWOX and p53 |
|
|
| Pingtao Liu,Mingyue Wang,Li Li,Tao Jin |
|
| Oncology Letters. 2017; 14(4): 4779 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma |
|
|
| Jie Wu,Ai Guo,Qiang Li,Difan Wang |
|
| Future Oncology. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis |
|
|
| Dong-dong Cheng,Hui-zhen Zhang,Jun-qing Yuan,Shi-jie Li,Qing-cheng Yang,Cun-yi Fan |
|
| Oncotarget. 2017; 8(16): 26380 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
